Christina Lake Cannabis (CLC) AI Stock Analysis

• Market Cap: C$12.39M
• Dividend Yield: N/A
• Average Volume (3M): 43.91K
• Price to Earnings (P/E): 6.8
• Beta (1Y): 0.49
• Revenue Growth: 15.54%
• EPS Growth: N/A
• Country: CA
• Employees: N/A
• Sector: Healthcare
• Sector Strength: 39
• Industry: Drug Manufacturers - Specialty & Generic
• EPS (TTM): <0.01
• Shares Outstanding: 225,315,350
• 10 Day Avg. Volume: 35,961
• 30 Day Avg. Volume: 43,905
• PEG Ratio: 0.09
• Price to Book (P/B): 1.13
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 31.83
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 58 Neutral
• Price Target: C$0.00 ▼(-100.00%Downside)

The overall stock score for Christina Lake Cannabis is influenced by strong revenue growth and a favorable valuation. However, operational inefficiencies, cash flow concerns, and increased leverage limit the score. Technical analysis shows short-term positive momentum, but overbought conditions indicate potential volatility. Recent corporate events present mixed impacts, with strategic financial moves balanced by compliance challenges.

Christina Lake Cannabis Business Overview & Revenue Model

Company Description

Christina Lake Cannabis (CLC) is a Canadian-based cannabis company that specializes in the cultivation, extraction, and sale of cannabis products. The company operates in the legal cannabis sector, focusing on producing high-quality, sun-grown cannabis and cannabis derivatives for both recreational and medicinal use. CLC is known for its sustainable growing practices and commitment to producing environmentally friendly products.

How the Company Makes Money

Christina Lake Cannabis makes money primarily through the cultivation and sale of cannabis and cannabis-derived products. The company's revenue streams include the wholesale of dried cannabis flower, the sale of cannabis oils, and the production of cannabis extracts such as distillates and isolates. CLC leverages its large-scale outdoor cultivation capabilities to produce high volumes of cannabis at competitive costs, which are then sold to licensed distributors and retailers. Additionally, the company may enter into strategic partnerships with other cannabis companies to expand its product offerings and reach new markets, further contributing to its earnings.

Christina Lake Cannabis Financial Statement Overview

Summary

Christina Lake Cannabis has shown commendable revenue growth and improved profitability over recent years. However, the company faces challenges with operational efficiency and cash flow management. Increased leverage adds financial risk, although asset growth and equity improvement are encouraging. Continuous focus on enhancing cash flow and managing debt levels will be essential for sustainable growth.

Income Statement

The company has shown significant revenue growth, increasing from $3.63 million in 2021 to $13.61 million in 2024. Gross profit margin in 2024 is strong at approximately 68.4%, indicating efficient cost management. However, the net profit margin remains low at approximately 6.4% in 2024, and EBIT was zero, suggesting potential operational efficiency issues. The company has transitioned from a net loss in previous years to a positive net income, reflecting improving financial performance.

Balance Sheet

The debt-to-equity ratio is relatively high at approximately 0.95 in 2024, indicating increased leverage, which could pose risks if not managed properly. Stockholders' equity has grown, showing a positive trend. The equity ratio is moderate at around 46.2%, suggesting a balanced approach to financing assets. Overall, while the company's leverage has increased, the growth in equity and assets is a positive sign.

Cash Flow

Free cash flow has significantly decreased from $0.78 million in 2023 to negative $4.13 million in 2024, indicating potential cash flow management issues. Operating cash flow to net income ratio is low, suggesting that net income is not effectively translating into cash flow. The company needs to focus on improving cash flow generation to support its operations and growth.

Breakdown	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	13.61M	11.78M	10.07M	3.63M	0.00
Gross Profit	9.31M	3.61M	2.98M	56.72K	4.77M
EBITDA	3.25M	-2.62M	-938.92K	-5.97M	-2.14M
Net Income	865.00K	-4.13M	-1.74M	-6.78M	-5.32M
Balance Sheet
Total Assets	23.37M	15.96M	18.79M	18.97M	17.80M
Cash, Cash Equivalents and Short-Term Investments	1.85M	1.47M	1.84M	1.08M	1.84M
Total Debt	10.27M	6.15M	6.45M	3.81M	4.06M
Total Liabilities	12.57M	8.50M	7.66M	9.23M	8.35M
Stockholders Equity	10.79M	7.46M	11.14M	9.74M	9.46M
Cash Flow
Free Cash Flow	-4.13M	781.46K	394.55K	-5.85M	-8.10M
Operating Cash Flow	221.02K	1.38M	1.18M	-4.62M	-3.32M
Investing Cash Flow	-4.47M	-571.37K	-790.41K	-1.20M	-4.78M
Financing Cash Flow	4.59M	-1.15M	369.17K	5.06M	9.20M

Christina Lake Cannabis Technical Analysis

• Technical Analysis Sentiment: Neutral
• Last Price: 0.04
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:CLC, the sentiment is Neutral. The current price of 0.04 is below the 20-day moving average (MA) of 0.04, below the 50-day MA of 0.05, and below the 200-day MA of 0.04, indicating a neutral trend. The MACD of <0.01 indicates Negative momentum. The RSI at 50.48 is Neutral, neither overbought nor oversold. The STOCH value of 77.78 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for TSE:CLC.

Christina Lake Cannabis Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
CLC	58 Neutral	C$12.39M	6.82	9.27%	―	15.54%	―
MPH	52 Neutral	C$13.25M	―	-8.79%	―	-0.29%	-53.83%
Sector *	52 Neutral	$7.50B	0.31	-61.87%	2.27%	17.10%	1.59%
TRIP	51 Neutral	$12.03M	―	-30.44%	―	13.57%	-14.29%
AVNT	48 Neutral	C$8.55M	―	-51.80%	―	32.63%	-90.15%
PWR	47 Neutral	C$8.77M	―	10.92%	―	-100.00%	62.10%
RVV	46 Neutral	C$8.37M	―	-50.76%	―	―	-4.84%

Christina Lake Cannabis Corporate Events

Christina Lake Cannabis Files Annual Financial Statements, Anticipates Cease Trade Order Revocation

Christina Lake Cannabis Corp. has filed its audited financial statements for the year ending February 28, 2025, on SEDAR+. This filing is expected to lead to the revocation of a management cease trade order, allowing the company’s directors and officers to resume trading in the company’s securities.

Christina Lake Cannabis Delays 2024 Financial Filings Amid Audit Challenges

Christina Lake Cannabis announced a delay in filing its 2024 annual financial statements due to extended audit processes and increased workload from recent acquisitions. The company is working with auditors to complete the filings by July 14, 2025, and has applied for a management cease trade order to prevent its CEO and CFO from trading until the filings are submitted.

Christina Lake Cannabis Completes First Tranche of Private Placement

Christina Lake Cannabis announced the closure of the first tranche of a non-brokered private placement, raising CDN $1,138,910.55 through the issuance of 22,778,211 units. This move, involving significant participation from company directors and officers, is part of a strategic financial maneuver to settle existing debts and is subject to regulatory approvals. The offering is expected to impact the company’s financial structure positively and potentially enhance its market positioning by strengthening its capital base.

Christina Lake Cannabis Launches $2.5M Private Placement

Christina Lake Cannabis Corp. announced a non-brokered private placement aiming to raise up to $2,500,000 through the issuance of units priced at $0.05 each. The proceeds will be used for constructing a new secured storage facility, purchasing equipment, and general working capital, potentially impacting the company’s operational capacity and market positioning.